» Articles » PMID: 28784721

Tet-Mediated DNA Demethylation Is Required for SWI/SNF-Dependent Chromatin Remodeling and Histone-Modifying Activities That Trigger Expression of the Sp7 Osteoblast Master Gene During Mesenchymal Lineage Commitment

Overview
Journal Mol Cell Biol
Specialty Cell Biology
Date 2017 Aug 9
PMID 28784721
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Here we assess histone modification, chromatin remodeling, and DNA methylation processes that coordinately control the expression of the bone master transcription factor Sp7 (osterix) during mesenchymal lineage commitment in mammalian cells. We find that Sp7 gene silencing is mediated by DNA methyltransferase1/3 (DNMT1/3)-, histone deacetylase 1/2/4 (HDAC1/2/4)-, Setdb1/Suv39h1-, and Ezh1/2-containing complexes. In contrast, Sp7 gene activation involves changes in histone modifications, accompanied by decreased nucleosome enrichment and DNA demethylation mediated by SWI/SNF- and Tet1/Tet2-containing complexes, respectively. Inhibition of DNA methylation triggers changes in the histone modification profile and chromatin-remodeling events leading to Sp7 gene expression. Tet1/Tet2 silencing prevents Sp7 expression during osteoblast differentiation as it impairs DNA demethylation and alters the recruitment of histone methylase (COMPASS)-, histone demethylase (Jmjd2a/Jmjd3)-, and SWI/SNF-containing complexes to the Sp7 promoter. The dissection of these interconnected epigenetic mechanisms that govern Sp7 gene activation reveals a hierarchical process where regulatory components mediating DNA demethylation play a leading role.

Citing Articles

Cell signaling and transcriptional regulation of osteoblast lineage commitment, differentiation, bone formation, and homeostasis.

Zhu S, Chen W, Masson A, Li Y Cell Discov. 2024; 10(1):71.

PMID: 38956429 PMC: 11219878. DOI: 10.1038/s41421-024-00689-6.


Epigenome editing revealed the role of DNA methylation of T-DMR/CpG island shore on Runx2 transcription.

Kawa Y, Shindo M, Ohgane J, Inui M Biochem Biophys Rep. 2024; 38:101733.

PMID: 38799114 PMC: 11127475. DOI: 10.1016/j.bbrep.2024.101733.


Aberrant DNA methylation distorts developmental trajectories in atypical teratoid/rhabdoid tumors.

Pekkarinen M, Nordfors K, Uusi-Makela J, Kytola V, Hartewig A, Huhtala L Life Sci Alliance. 2024; 7(6).

PMID: 38499326 PMC: 10948937. DOI: 10.26508/lsa.202302088.


G-protein coupled receptor 5C (GPRC5C) is required for osteoblast differentiation and responds to EZH2 inhibition and multiple osteogenic signals.

Dashti P, Thaler R, Hawse J, Galvan M, van der Eerden B, van Wijnen A Bone. 2023; 176:116866.

PMID: 37558192 PMC: 10962865. DOI: 10.1016/j.bone.2023.116866.


Atf7ip Inhibits Osteoblast Differentiation via Negative Regulation of the Sp7 Transcription Factor.

Hu G, Shi X, Qu X, Han C, Hu A, Jia Z Int J Mol Sci. 2023; 24(5).

PMID: 36901736 PMC: 10002255. DOI: 10.3390/ijms24054305.


References
1.
Kruidenier L, Chung C, Cheng Z, Liddle J, Che K, Joberty G . A selective jumonji H3K27 demethylase inhibitor modulates the proinflammatory macrophage response. Nature. 2012; 488(7411):404-8. PMC: 4691848. DOI: 10.1038/nature11262. View

2.
Helin K, Dhanak D . Chromatin proteins and modifications as drug targets. Nature. 2013; 502(7472):480-8. DOI: 10.1038/nature12751. View

3.
Barbuto R, Mitchell J . Regulation of the osterix (Osx, Sp7) promoter by osterix and its inhibition by parathyroid hormone. J Mol Endocrinol. 2013; 51(1):99-108. PMC: 3685218. DOI: 10.1530/JME-12-0251. View

4.
Shechter D, Dormann H, Allis C, Hake S . Extraction, purification and analysis of histones. Nat Protoc. 2007; 2(6):1445-57. DOI: 10.1038/nprot.2007.202. View

5.
Lee J, Lee T . Effects of histone acetylation and CpG methylation on the structure of nucleosomes. Biochim Biophys Acta. 2012; 1824(8):974-82. PMC: 3565240. DOI: 10.1016/j.bbapap.2012.05.006. View